Study objectives: To evaluate the chest radiographic filling pattern associ
ated with partial liquid ventilation (PLV) with the perfluorochemical perfl
ubron (LiquiVent; Alliance Pharmaceutical Corp; San Diego CA) as a function
of dose and timing.
Design: Post hoc review of chest radiographs by three independent observers
with correlation to clinical variables. Setting: Phase II randomized, unco
ntrolled, prospective, multicenter clinical trial.
Patients: Sixteen adult patients with diffuse bilateral infiltrates consist
ent with acute lung injury and a Pao(2)/fraction of inspired oxygen (FIO2)
ratio < 300 with positive end-expiratory pressure of 13 cm H2O and FIO2 <gr
eater than or equal to> 0.5.
Interventions: All patients were treated with either a 10-mL/kg or 20-mL/kg
loading dose of perflubron followed by maintenance dosing at 3-h intervals
to protocol-determined levels.
Results: There was a significant relationship between inhomogeneous radiogr
aphic filling during the first 48 h of treatment and the use of the lower l
oading dose of perflubron. Inhomogeneous radiographic filling (in 5 patient
s) was associated with a lower high-dose/FIO2 ratio at 24 h compared with t
he remaining patients. These differences resolved by 48 h. There were no ot
her statistically significant correlations identified.
Conclusions: The radiographic appearance of PLV with perflubron appears to
depend on the dose administered. Lower doses can be associated with both in
homogeneous radiographic filling and a transient deterioration in oxygenati
on during the first 24 to 48 h of treatment.